Literature DB >> 18033026

[Cystathionine betasynthase and MTHFR deficiencies in adults].

F Cohen Aubart1, F Sedel, T Papo.   

Abstract

INTRODUCTION: Homocysteine lies at an important metabolic branch point; it may be either converted to cystathionine through the transsulfuration pathway, or methylated to form methionine. Hyperhomocysteinemia may result from hereditary defects affecting one of these reactions. STATE OF ART: Cystathionine beta synthase or 5,10-methylenetetrahydrofolate deficiency can both result in homocystinuria. Current knowledge about biochemical mechanisms leading to hyperhomocysteinemia, clinical and radiological features, pathogenesis and treatment are reviewed, focusing on late onset forms of these diseases which can be diagnosed in adulthood. CBS deficiency is characterized by lens dislocation, skeletal abnormalities, neurologic disturbances and thromboembolism. MTHFR deficiency leads to various neurological symptoms, ranging from developmental delay to encephalopathy, including motor and gait abnormalities, seizures, psychiatric manifestations and rarely strokes. The treatment of CBS deficiency depends on vitamin B6, whereas MTHFR deficiency can be efficiently treated by vitamin B12, folic acid, and betaine. PERSPECTIVES: Homocysteinemia should be measured in patients with unexplained neurological manifestations or thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033026     DOI: 10.1016/s0035-3787(07)92633-8

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  4 in total

1.  Spinocerebellar ataxia: a rational approach to aetiological diagnosis.

Authors:  Adrian Degardin; Dries Dobbelaere; Isabelle Vuillaume; Sabine Defoort-Dhellemmes; Jean-François Hurtevent; Bernard Sablonnière; Alain Destée; Luc Defebvre; David Devos
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

2.  CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies.

Authors:  Andrew D Johnson; Anupama Bhimavarapu; Emelia J Benjamin; Caroline Fox; Daniel Levy; Gail P Jarvik; Christopher J O'Donnell
Journal:  Genet Med       Date:  2010-06       Impact factor: 8.822

3.  Phoenix from the ashes: dramatic improvement in severe late-onset methylenetetrahydrofolate reductase (MTHFR) deficiency with a complete loss of vision.

Authors:  Anne-Sophie Biesalski; Sabine Hoffjan; Ruth Schneider; Huu Phuc Nguyen; Gabriele Dekomien; Thomas Lücke; Christiane Schneider-Gold; Britta Matusche; Ralf Gold; Ilya Ayzenberg
Journal:  J Neurol       Date:  2021-10-17       Impact factor: 4.849

Review 4.  Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes.

Authors:  Ana Gales; Marion Masingue; Stephanie Millecamps; Stephane Giraudier; Laure Grosliere; Claude Adam; Claudio Salim; Vincent Navarro; Yann Nadjar
Journal:  Orphanet J Rare Dis       Date:  2018-02-01       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.